Hypothetical case - For market research purposes only
Related Articles
-
Eyecare Evaluation Guide
Learn important information about corneal adverse reactions associated with BLENREP, adverse event management, and instructions to facilitate communication between prescribers and eye care professionals for patients prescribed BLENREP.Read more » -
The DREAMM-2 Clinical Trial
Learn about DREAMM-2, which evaluated the efficacy and safety of belantamab mafodotin-blmf in patients with relapsed or refractory multiple myeloma including failure to prior treatment with an anti-CD38 antibody.Read more »
Gsk.com